Topic: How To Invest

Wall Street Stock Forecaster Hotline – Friday, May 13, 2022

Article Excerpt

PFIZER INC., $49.92, New York symbol PFE, is your #1 Income Buy for 2022. The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica (epilepsy), Celebrex and Enbrel (arthritis), and Prevnar (pneumonia). Pfizer has raised its dividend rate each year since 2011. The latest increase came in March 2022 when the company lifted your quarterly payment by 2.6%. Investors now receive $0.40 a share instead of $0.39. The new annual rate of $1.60 yields a solid 3.2%. The company is now buying full control of Biohaven Pharmaceutical Holding Company Ltd. (New York symbol BHVN). That firm’s main product is Nurtec, a treatment for migraine headaches. Pfizer recently paid $350 million for a 2.6% stake in Biohaven as part of a deal to market Nurtec outside of the U.S. It will now buy the remaining 97.4% of the shares for $11.6 billion in cash. To put these figures in context, the company earned $9.39 billion, or $1.62 a..